Found: 7
Select item for more details and to access through your institution.
Novel Multidisciplinary Approach for Outpatient Antimicrobial Stewardship Using an Emergency Department Follow-Up Program.
- Published in:
- Journal of Pharmacy Practice, 2023, v. 36, n. 2, p. 329, doi. 10.1177/08971900211048311
- By:
- Publication type:
- Article
Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 8, p. 1, doi. 10.1093/ofid/ofab313
- By:
- Publication type:
- Article
1441. Comparison of Cefpodoxime vs. Oral Cefuroxime for Urinary Tract Infections at a Large Academic Medical Center.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S526, doi. 10.1093/ofid/ofz360.1305
- By:
- Publication type:
- Article
A rare fungus on the rise: Candida auris.
- Published in:
- American Journal of Health-System Pharmacy, 2018, v. 75, n. 14, p. 1013, doi. 10.2146/ajhp170640
- By:
- Publication type:
- Article
Expanding the scope and visibility of ambulatory stewardship programs with novel coronavirus disease 2019 (COVID-19) therapeutics.
- Published in:
- Antimicrobial Stewardship & Healthcare Epidemiology, 2022, v. 2, n. 1, p. 1, doi. 10.1017/ash.2022.52
- By:
- Publication type:
- Article
Non-randomized evaluation of hospitalization after a prescription for nirmatrelvir/ritonavir versus molnupiravir in high-risk COVID-19 outpatients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 7, p. 1683, doi. 10.1093/jac/dkad154
- By:
- Publication type:
- Article
Assessment of unvaccinated and vaccinated patients with coronavirus disease 2019 (COVID-19) treated with monoclonal antibodies during the delta wave (July 1-August 20, 2021): a retrospective observational monocentric study.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07626-6
- By:
- Publication type:
- Article